United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Japanese group AGC offers €240m bid for Italian biotech company Molmed Japanese conglomerate AGC has offered a takeover bid of €240 million to acquire 100% of Italian biotech company… bypharmanewsdailyMarch 18, 2020
